Stoker AW - Search Results

1

Irving E, Stoker AW. Irving E, et al. Among authors: stoker aw. Molecules. 2017 Dec 19;22(12):2269. doi: 10.3390/molecules22122269. Molecules. 2017. PMID: 29257048 Free PMC article. Review.

2

Liposomal delivery of hydrophobic RAMBAs provides good bioavailability and significant enhancement of retinoic acid signalling in neuroblastoma tumour cells.

Bilip M, Shah S, Mathiyalakan M, Tagalakis AD, Hart SL, Maeshima R, Eaton S, Orford M, Irving E, Di Florio A, Simons C, Stoker AW. Bilip M, et al. Among authors: stoker aw. J Drug Target. 2020 Jul;28(6):643-654. doi: 10.1080/1061186X.2019.1710157. Epub 2020 Jan 14. J Drug Target. 2020. PMID: 31903789 Free PMC article.

3

The liposomal delivery of hydrophobic oxidovanadium complexes imparts highly effective cytotoxicity and differentiating capacity in neuroblastoma tumour cells.

Irving E, Tagalakis AD, Maeshima R, Hart SL, Eaton S, Lehtonen A, Stoker AW. Irving E, et al. Among authors: stoker aw. Sci Rep. 2020 Oct 7;10(1):16660. doi: 10.1038/s41598-020-73539-6. Sci Rep. 2020. PMID: 33028860 Free PMC article.

4

Tyrosine phosphatase inhibitors combined with retinoic acid can enhance differentiation of neuroblastoma cells and trigger ERK- and AKT-dependent, p53-independent senescence.

Clark O, Daga S, Stoker AW. Clark O, et al. Among authors: stoker aw. Cancer Lett. 2013 Jan 1;328(1):44-54. doi: 10.1016/j.canlet.2012.09.014. Epub 2012 Sep 26. Cancer Lett. 2013. PMID: 23022267

5

Receptor tyrosine phosphatase PTPγ is a regulator of spinal cord neurogenesis.

Hashemi H, Hurley M, Gibson A, Panova V, Tchetchelnitski V, Barr A, Stoker AW. Hashemi H, et al. Among authors: stoker aw. Mol Cell Neurosci. 2011 Feb;46(2):469-82. doi: 10.1016/j.mcn.2010.11.012. Epub 2010 Nov 26. Mol Cell Neurosci. 2011. PMID: 21112398 Free PMC article.

6

Protein tyrosine phosphatases and signalling.

Stoker AW. Stoker AW. J Endocrinol. 2005 Apr;185(1):19-33. doi: 10.1677/joe.1.06069. J Endocrinol. 2005. PMID: 15817824 Review.

7

Detection and Identification of Ligands for Mammalian RPTP Extracellular Domains.

Stoker AW. Stoker AW. Methods Mol Biol. 2016;1447:267-81. doi: 10.1007/978-1-4939-3746-2_15. Methods Mol Biol. 2016. PMID: 27514811

8

Receptor tyrosine phosphatases in axon growth and guidance.

Stoker AW. Stoker AW. Curr Opin Neurobiol. 2001 Feb;11(1):95-102. doi: 10.1016/s0959-4388(00)00179-3. Curr Opin Neurobiol. 2001. PMID: 11179878 Review.

9

Oxovanadium-based inhibitors can drive redox-sensitive cytotoxicity in neuroblastoma cells and synergise strongly with buthionine sulfoximine.

Clark O, Park I, Di Florio A, Cichon AC, Rustin S, Jugov R, Maeshima R, Stoker AW. Clark O, et al. Among authors: stoker aw. Cancer Lett. 2015 Feb 1;357(1):316-327. doi: 10.1016/j.canlet.2014.11.039. Epub 2014 Nov 20. Cancer Lett. 2015. PMID: 25444896 Free article.

10

The cytotoxic action of BCI is not dependent on its stated DUSP1 or DUSP6 targets in neuroblastoma cells.

Thompson EM, Patel V, Rajeeve V, Cutillas PR, Stoker AW. Thompson EM, et al. Among authors: stoker aw. FEBS Open Bio. 2022 Jul;12(7):1388-1405. doi: 10.1002/2211-5463.13418. Epub 2022 May 6. FEBS Open Bio. 2022. PMID: 35478300 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

63 results

Search Page